MLSS
Milestone Scientific Inc.
Healthcare · Medical Instruments & Supplies · ASE
$0.42
Data: 2026-05-15
✓ ETHICAL PASS

MOAT
HIGH
Data Confidence: 85.7%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$29M
Total market value of the company
Trailing P/E
N/A
Forward P/E
-8.21
Based on estimated future earnings — lower means cheaper
Rev Growth
-3.2%
Year-over-year revenue change
Profit Margin
-51.3%
How much profit the company keeps from each dollar of revenue
ROE
-135.4%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$1.00
+138% from current price — median analyst estimate
Recommendation
NONE
Consensus view from 2 analysts covering this stock
About Milestone Scientific Inc.

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

https://www.milestonescientific.com

Country: United States Employees: 15 Industry: Medical Instruments & Supplies
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
3.3% PASS
Debt must be below 33% of total assets
Cash Ratio
3.6% PASS
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime
MARKUP
Price trending up with increasing momentum
Sharpe Ratio
0.028
Positive but modest risk-adjusted returns
Kelly Fraction
-0.1578
No positive edge detected — the data suggests staying out
Calmar Ratio
-0.357
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-29.0%
Historical annualised return based on price data
Max Drawdown
-81.2%
Largest peak-to-trough decline — the worst it has been
HMM State
BEAR
Statistical model detects bearish conditions
Days in State
46
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

Beta
N/A
52W High
$1.05
60% below the year high
52W Low
$0.22
91% above the year low
Avg Volume
2,106,674
Average daily shares traded — higher means easier to buy and sell
Short Ratio
0.5
Days it would take all short sellers to cover — higher means more crowded
Short % Float
3.4%
Low short interest — limited bearish positioning
Div Yield
0.0%
Annual dividend as a percentage of the share price
EPS (TTM)
$-0.07
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity
0.43
Conservative use of debt — low financial risk
Current Ratio
1.51
Healthy liquidity position
Quick Ratio
0.37
Like current ratio but excludes inventory — stricter test
Gross Margin
71.0%
Revenue left after cost of goods — higher means pricing power
Operating Margin
-38.3%
Profit from core operations before interest and tax
Free Cash Flow
$626,510
Positive — the business generates more cash than it spends
Revenue (TTM)
$9M
Total revenue over the last 12 months
Net Income
$-4,567,483
Loss-making — spending exceeds revenue after all costs
Analyst Coverage
Analysts
2
Target High
$1.00
Target Median
$1.00
Target Low
$1.00
Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date Insider Title Type Shares Value
2025-10-24 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 194,427 $84,884
2025-10-21 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 64,034 $28,472
2025-10-14 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 50,158 $27,273
2025-10-08 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 40,000 $18,450
2025-10-03 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 19,210 $8,636
2025-09-11 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 10,000 $5,940
2025-07-17 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 10,000 $6,400
2025-07-08 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 92,900 $62,798
2025-06-30 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 27,882 $21,882
2025-06-18 BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security 11,749 $10,491
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.